NYECC Acquires the First OCT2 Machine for Clinical Use in United States
![](https://eyecancer.com/wp-content/uploads/2015/12/17a7888e177a4ab5b81a5444a4d2b897-150x150.png)
The New York Eye Cancer Center is thrilled to announce it is the first clinic in the United States to use the state-of-art OCT2 imaging machine from Heidelberg Engineering. The machine was publicly released earlier this year and installed at NYECC the week before Christmas. It reflects Dr. Finger’s continuing commitment to provide cutting-edge, next-generation eye cancer care. Dr. Finger [..] Read More…